CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death

被引：0
|
作者：
Alexander H. Chung
Tina M. Leisner
Gabrielle J. Dardis
Marissa M. Bivins
Alana L. Keller
Leslie V. Parise
机构：
[1] University of North Carolina at Chapel Hill,Department of Pharmacology
[2] University of North Carolina at Chapel Hill,Department of Biochemistry and Biophysics
[3] Lineberger Comprehensive Cancer Center,undefined
来源：
Cancer Cell International | / 19卷
关键词：
CIB1; TRAIL; Apoptosis; Triple-negative breast cancer; Chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
    Chung, Alexander H.
    Leisner, Tina M.
    Dardis, Gabrielle J.
    Bivins, Marissa M.
    Keller, Alana L.
    Parise, Leslie V.
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [2] Potent treatment combinations with CIB1 depletion in triple-negative breast cancer
    Chung, Alexander H.
    Leisner, Tina M.
    Dardis, Gabrielle
    Bivins, Marissa
    Parise, Leslie V.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer
    Justin L. Black
    J. Chuck Harrell
    Tina M. Leisner
    Melissa J. Fellmeth
    Samuel D. George
    Dominik Reinhold
    Nicole M. Baker
    Corbin D. Jones
    Channing J. Der
    Charles M. Perou
    Leslie V. Parise
    Breast Cancer Research and Treatment, 2015, 152 : 337 - 346
  • [4] CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer
    Black, Justin L.
    Harrell, J. Chuck
    Leisner, Tina M.
    Fellmeth, Melissa J.
    George, Samuel D.
    Reinhold, Dominik
    Baker, Nicole M.
    Jones, Corbin D.
    Der, Channing J.
    Perou, Charles M.
    Parise, Leslie V.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (02) : 337 - 346
  • [5] In silico Mutagenesis and Modeling of Decoy Peptides Targeting CIB1 to Obscure its Role in Triple-negative Breast Cancer Progression
    Shahab, Muhammad
    Liang, Chaoqun
    Duan, Xiuyuan
    Zheng, Guojun
    Wadood, Abdul
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (08) : 630 - 638
  • [6] Piperine Enhances the Efficacy of TRAIL-based Therapy for Triple-negative Breast Cancer Cells
    Abdelhamed, Sherif
    Yokoyama, Satoru
    Refaat, Alaa
    Ogura, Keisuke
    Yagita, Hideo
    Awale, Suresh
    Saiki, Ikuo
    ANTICANCER RESEARCH, 2014, 34 (04) : 1893 - 1899
  • [7] Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
    Kundu, Manjari
    Greer, Yoshimi Endo
    Dine, Jennifer L.
    Lipkowitz, Stanley
    CELLS, 2022, 11 (23)
  • [8] Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
    Li Xintong
    Tang Lin
    Chen Qin
    Cheng Xumin
    Liu Yiqiu
    Wang Cenzhu
    Zhu Chengjun
    Xu Kun
    Gao Fangyan
    Huang Jinyi
    Wang Runtian
    Guan Xiaoxiang
    中华医学杂志英文版, 2022, 135 (20)
  • [9] Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer
    Li, Xintong
    Tang, Lin
    Chen, Qin
    Cheng, Xumin
    Liu, Yiqiu
    Wang, Cenzhu
    Zhu, Chengjun
    Xu, Kun
    Gao, Fangyan
    Huang, Jinyi
    Wang, Runtian
    Guan, Xiaoxiang
    CHINESE MEDICAL JOURNAL, 2022, 135 (20) : 2436 - 2445
  • [10] Effect of punicalagin on the autophagic cell death in triple-negative breast cancer cells
    Bhutta, Zeeshan Ahmad
    Go, Ryeo-Eun
    Choi, Kyung-Chul
    TOXICOLOGICAL RESEARCH, 2024, 40 (04) : 585 - 598
12345